Antibody responses in patients with invasive infections
Résumé
Correlation between antibody response and clinical outcome in bacteremia has yielded conflicting results. Immunization schedules have failed in clinical trials. Is the humoral response toward of protective nature? A prospective study was performed in patients with invasive (ISA) infections during the period 2003-2005. The antibody levels were determined at the beginning and at the end of treatment and one month later ( = 96, = 71, and = 51, respectively). As controls, 115 healthy individuals were used. A quantitative enzyme-linked immunosorbent assay (ELISA) against eight purified antigens was performed. Bacterial isolates were grouped as to the production of alpha-toxin, type, and pulsed-field gel electrophoresis (PFGE) type. Large variations were seen in the antibody levels. The levels in the second sample were the highest. A correlation between group, PFGE group, alpha-toxin production, and initial antibody levels was observed. Patients with fatal outcome displayed lower initial antibody levels to all antigens and significantly so in regard to teichoic acid, lipase, enterotoxin A, and scalded skin syndrome toxin. In episodes with complicated bacteremia, initial significantly low levels to teichoic acid and lipase were registered. Low initial antibody levels against several antigens were associated with increased mortality and complicated bacteremia in invasive infections. Bacterial properties, strain, and toxin production affected the antibody response.
Origine : Fichiers produits par l'(les) auteur(s)
Loading...